When Kristine Dalton (OD '07, MSc '10) first stepped into a meeting on Paralympic classification more than a decade ago, she ...

When Kristine Dalton (OD ’07, MSc ’10) first stepped into a meeting on Paralympic classification more than a decade ago, she had no idea it would change the trajectory of her career or the landscape ...

Phase 1/2a Clinical Study 36 Month Results Featured at Clinical Trials at the Summit 2025Achieved First Milestone Under Worldwide Collaboration with Genentech Based on RG6501 (OpRegen Cell Therapy) ...

Good morning, and welcome once again to TD Cowen's 46th Annual Healthcare Conference. I'm Phil Nadeau, one of the biotech analysts here at Cowen, and it's my pleasure to moderate a fireside chat with ...